Navigation Links
Money Matters When Choosing an Infertility Treatment

If advice is cheap, ART — assisted reproductive technology — is not, and the difference in cost has a significant effect on the treatments pursued by infertile couples in the United States.//

Not surprisingly, an infertile couple’s income makes a difference in whether they pursue an expensive technology such as in vitro fertilization, but income and insurance coverage also have a strong impact on whether they choose less costly options such as medication and surgery, according to a new study in the journal Health Services Research.

Income and insurance did not affect whether couples sought out a doctor’s advice, the lowest-cost and least effective type of treatment, say J. Farley Ordovensky Staniec, Ph.D., of the University of the Pacific in Stockton, Calif., and Natalie Webb, Ph.D., of the Naval Postgraduate School in Monterey.

“For the 11 percent of women of childbearing age facing fertility problems and considering their options, money does matter,” Staniec said.

The researchers looked at 1995 survey data from nearly 11,000 women, 1,210 of whom had fertility problems or were part of a couple with fertility problems. Of the 1,091 women ages 22 and older with problems, nearly six percent sought advice only from their doctors, 7 percent had fertility tests but no other treatment, 11 percent used drugs to induce ovulation but no other treatments, 3 percent had surgery and nearly 6 percent pursued treatments such as in vitro fertilization and related procedures.

By comparing these treatment options with information about the women’s income and insurance, Staniec and Webb found that low-income women were only 65 percent as likely as their richer counterparts to seek help for infertility.

However, treatment costs influenced treatment choices for most women in the study, the researchers concluded. “For options beyond ‘advice only,’ income plays a significant role in all but the choice to use ovulatio
'"/>




Page: 1 2

Related medicine news :

1. B Vitamin Supplementatoin Saves Money and Lives
2. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
3. Finance Problems Result In Money Sickness Syndrome
4. Losing Sleep over Money or Money over Sleep? Sleep over It!
5. The Long Wait Continues In the Health Care Service despite the Money Factor
6. NHS Forced to Borrow Money at Rates of 10 percent
7. Money Matter Even To the Brain
8. Health Promotion Drives Waste Money, Claim Nurses
9. Failure to Keep Appointments causing Loss of Money
10. Money Allocated for Child Welfare Programme In Kashmir
11. Money Spent On Cancer worth Every Penny
Post Your Comments:
(Date:7/8/2008)...following statement was issued,today by the law fi...otice is hereby given that a class action lawsuit ...the Middle District of Tennessee on behalf,of all ...q: HWAY ),("Healthways" or the "Company") from Oc...e (the "Class Period")., If you wish to discuss t...
(Date:7/8/2008)...elays in Oxygen Orders, Lack of,Trained Technician... -- The new Medicare,competitive bidding program f...nd chaos for beneficiaries, physicians, hospital d...viders across the country since it,was implemented... program has triggered widespread disruptions in s...
(Date:7/8/2008)...ociety of Hematology (ASH) is proud to announce th... Pathway Grant. The grant is given to training pro...plementation of novel hematology-related training ...sity, Donald Mahoney Jr., MD, of Baylor College of...Sinai School of Medicine, will each receive the gr...
(Date:7/8/2008)...os Innovation,s Proprietary,Device-Free Remote Mo... and Medical Costs, N...ovations, a pioneer,in assisting clients to achiev...ce improvement through a device-free remote monito...e Iowa Medicaid Congestive Heart Failure,Populatio...
Breaking Medicine News(10 mins):Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 2Health News:Shareholder Class Action Filed Against Healthways Inc. By The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3
...test developed by a team led by a University of Le...rnment’s Independent Depleted Uranium// Oversight ...uranium (DU) during the 1991 Gulf Conflict. Ra...ology, developed the test with Postdoctoral Fellow...
...udying the genetic make-up using blood samples to ...g treatment, has been in practice//. Now, scientis...thods based on such existing tests that might reve...come victims of substance abuse or suffer antisoci...
...University of Iowa study has revealed that it may ...ions like panic disorder with blood tests//. This ...information in immature white blood cells. "The ...quantum leap in psychiatry," said the study's lead...
...searchers in the United States have developed a me...ll four types of the dengue// virus. The dengue v...cephalitis. The four types of virus are all suffic...iduals vaccinated against one virus type are still...
Other Medicine News:Health News:DU Test Finds UK Troops Uranium Free 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 3Health News:Mental Health Conditions Could Be Detected With Blood Tests 2
(Date:7/7/2008)...- Light Sciences Oncology, Inc.,(LSO) today announ...enign,prostatic hyperplasia (BPH), or enlargement ...(Litx(TM)), an innovative light-activated drug,tre...2-patient, Phase I/II,dose-escalation study at fou...nt, Phase IIa study in Australia, expected to begi...
(Date:7/7/2008)...irstCall/ -- Biopure Corporation,(Nasdaq: BPUR ) ...he Food,and Drug Administration (FDA) on identifyi...ical trial of Hemopure(R) [hemoglobin glutamer -,2... study use of Hemopure,in patients suffering from ...usion with blood components. Currently, AML patien...
(Date:7/6/2008)...horization Application currently ...- Cell Therapeutics, Inc. (...lication of results from its,randomized phase III ...,CT-2103) with gemcitabine or vinorelbine for the ...with previously untreated non-small cell,lung canc...
(Date:7/3/2008)...sachusetts, July 3,/-, -...ny, Jerini AG for an equity purchase price of EUR...oduct, FIRAZYR(R), to its Human Genetic Therapies ...es expected to be around $350-400 million, based ...ent, - Expected to be accretive for Non GAAP earn...
Breaking Medicine Technology:Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate 2Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate 3Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 1Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 2Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 3Drug Resistant Staph Infections Reaching Epidemic Levels in Some Parts of U S 4151 4Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 1Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 2Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 3Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 4Syngenta Licenses Chromatin Gene Stacking Technology 1373 1Syngenta Licenses Chromatin Gene Stacking Technology 1373 2Research approved for Hawaiian military training area 888 1Research approved for Hawaiian military training area 888 2
...nt Plans - , ,OTTAWA, Canada – March 7, 2007...al company specializing in developing,advanced pro...ften,called “good cholesterol,” today ... of its lead product, CRD5. CRD5 is,being develope...ase. , ,Results showed, to date, that CRD5 was saf...
... 12, 2007 - Ceragenix Pharmaceuticals,Inc. (OTCBB...ectious disease and dermatology, today announced t...emonstrated virtually no biofilm,formation in a 21...treated with Ceragenins,were soaked daily in a pho...atheter. At day 21, the catheters were challenged ...
Other Medicine Technology:Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 2Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5 3Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: